Search clinical trials for: SGX201 (delayed release beclomethasone 17,21-dipropionate)

Total 6 results

Soligenix
National Cancer Institute (NCI)

Completed

A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer

Enteritis

United States
SOFAR S.p.A.

Completed

Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers

Healthy Adult Male Volunteers

Italy
Soligenix

Terminated

Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)

Chronic Gastrointestinal Graft vs Host Disease

United States
Soligenix

Terminated

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD) (SUPPORTS)

Acute Gastrointestinal Graft vs Host Disease

United States
ROC Foundation

Completed

Effect of ZILRETTA Versus CELESTONE on Quality of Life, Pain, Neuromuscular Function, and Physical Performance

Osteoarthritis, Knee

United States
Universidad Autonoma de Nuevo Leon

Completed

Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis.

Plantar Fascitis | Botulinum Toxins, Type A

Mexico

3

Subscribe